ATE478050T1 - Chinolinderivate mit 5-ht-bindenden eigenschaften - Google Patents
Chinolinderivate mit 5-ht-bindenden eigenschaftenInfo
- Publication number
- ATE478050T1 ATE478050T1 AT07803542T AT07803542T ATE478050T1 AT E478050 T1 ATE478050 T1 AT E478050T1 AT 07803542 T AT07803542 T AT 07803542T AT 07803542 T AT07803542 T AT 07803542T AT E478050 T1 ATE478050 T1 AT E478050T1
- Authority
- AT
- Austria
- Prior art keywords
- binding properties
- quinoline derivatives
- quinoline
- derivatives
- binding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06121449 | 2006-09-28 | ||
| PCT/EP2007/059840 WO2008037626A1 (en) | 2006-09-28 | 2007-09-18 | Quinoline derivatives with 5-ht-binding properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE478050T1 true ATE478050T1 (de) | 2010-09-15 |
Family
ID=38925599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07803542T ATE478050T1 (de) | 2006-09-28 | 2007-09-18 | Chinolinderivate mit 5-ht-bindenden eigenschaften |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7825253B2 (de) |
| EP (1) | EP2076495B1 (de) |
| JP (1) | JP5111509B2 (de) |
| KR (1) | KR101088451B1 (de) |
| CN (1) | CN101516852B (de) |
| AR (1) | AR062994A1 (de) |
| AT (1) | ATE478050T1 (de) |
| AU (1) | AU2007302061B2 (de) |
| BR (1) | BRPI0717140A2 (de) |
| CA (1) | CA2664031A1 (de) |
| CL (1) | CL2007002768A1 (de) |
| DE (1) | DE602007008597D1 (de) |
| ES (1) | ES2347193T3 (de) |
| IL (1) | IL197301A0 (de) |
| MX (1) | MX2009003170A (de) |
| PE (1) | PE20080898A1 (de) |
| TW (1) | TW200819433A (de) |
| WO (1) | WO2008037626A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2669590A1 (en) * | 2006-12-07 | 2008-06-12 | F. Hoffmann-La Roche Ag | 2-aminoquinolines as 5-ht(5a) receptor antagonists |
| CN101808999B (zh) * | 2007-09-27 | 2013-02-13 | 弗·哈夫曼-拉罗切有限公司 | 用作5ht5a受体拮抗剂的喹啉衍生物 |
| MX2010009643A (es) * | 2008-03-07 | 2010-09-22 | Hoffmann La Roche | Derivados de 2-aminoquinolina como antagonistas del receptor 5-hidroxitriptamina (5a). |
| BRPI0910253A2 (pt) | 2008-03-07 | 2015-09-29 | Hoffmann La Roche | derivados de 2-aminoquinolina |
| AU2009224760A1 (en) * | 2008-03-12 | 2009-09-17 | F. Hoffmann-La Roche Ag | 2-Aminoquinolines as 5-HT5A receptor antagonists |
| AR116628A1 (es) | 2018-10-18 | 2021-05-26 | Syngenta Crop Protection Ag | Compuestos microbiocidas |
| GB201903942D0 (en) | 2019-03-22 | 2019-05-08 | Syngenta Crop Protection Ag | Microbiocidal compounds |
| CN115209736A (zh) | 2020-03-05 | 2022-10-18 | 先正达农作物保护股份公司 | 杀真菌组合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0103648D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic quinolone compounds |
| SE0103649D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic quinoline compounds |
| US7084156B2 (en) * | 2001-11-27 | 2006-08-01 | Merck & Co., Inc. | 2-Aminoquinoline compounds |
| SE0202134D0 (sv) | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Therapeutic agents |
| GB0309781D0 (en) | 2003-04-29 | 2003-06-04 | Glaxo Group Ltd | Compounds |
| GB0312609D0 (en) * | 2003-06-02 | 2003-07-09 | Astrazeneca Ab | Novel compounds |
| JP2005154434A (ja) * | 2003-11-05 | 2005-06-16 | Kyowa Hakko Kogyo Co Ltd | ２−アミノキナゾリン誘導体 |
-
2007
- 2007-09-18 AT AT07803542T patent/ATE478050T1/de active
- 2007-09-18 EP EP07803542A patent/EP2076495B1/de not_active Not-in-force
- 2007-09-18 WO PCT/EP2007/059840 patent/WO2008037626A1/en active Application Filing
- 2007-09-18 CA CA002664031A patent/CA2664031A1/en not_active Abandoned
- 2007-09-18 MX MX2009003170A patent/MX2009003170A/es active IP Right Grant
- 2007-09-18 JP JP2009529658A patent/JP5111509B2/ja not_active Expired - Fee Related
- 2007-09-18 DE DE602007008597T patent/DE602007008597D1/de active Active
- 2007-09-18 KR KR1020097005608A patent/KR101088451B1/ko not_active IP Right Cessation
- 2007-09-18 CN CN2007800353406A patent/CN101516852B/zh not_active Expired - Fee Related
- 2007-09-18 ES ES07803542T patent/ES2347193T3/es active Active
- 2007-09-18 AU AU2007302061A patent/AU2007302061B2/en not_active Ceased
- 2007-09-18 BR BRPI0717140-4A2A patent/BRPI0717140A2/pt not_active IP Right Cessation
- 2007-09-21 US US11/859,045 patent/US7825253B2/en not_active Expired - Fee Related
- 2007-09-26 AR ARP070104247A patent/AR062994A1/es unknown
- 2007-09-26 CL CL200702768A patent/CL2007002768A1/es unknown
- 2007-09-27 TW TW096135979A patent/TW200819433A/zh unknown
- 2007-09-27 PE PE2007001313A patent/PE20080898A1/es not_active Application Discontinuation
-
2009
- 2009-02-26 IL IL197301A patent/IL197301A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE20080898A1 (es) | 2008-08-06 |
| CN101516852A (zh) | 2009-08-26 |
| JP5111509B2 (ja) | 2013-01-09 |
| AR062994A1 (es) | 2008-12-17 |
| TW200819433A (en) | 2008-05-01 |
| BRPI0717140A2 (pt) | 2013-10-22 |
| CN101516852B (zh) | 2011-11-16 |
| DE602007008597D1 (de) | 2010-09-30 |
| US7825253B2 (en) | 2010-11-02 |
| JP2010504939A (ja) | 2010-02-18 |
| KR20090042977A (ko) | 2009-05-04 |
| US20080081907A1 (en) | 2008-04-03 |
| ES2347193T3 (es) | 2010-10-26 |
| CL2007002768A1 (es) | 2008-04-18 |
| WO2008037626A1 (en) | 2008-04-03 |
| KR101088451B1 (ko) | 2011-12-01 |
| AU2007302061B2 (en) | 2012-01-19 |
| CA2664031A1 (en) | 2008-04-03 |
| AU2007302061A1 (en) | 2008-04-03 |
| MX2009003170A (es) | 2009-04-03 |
| IL197301A0 (en) | 2009-12-24 |
| EP2076495B1 (de) | 2010-08-18 |
| EP2076495A1 (de) | 2009-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0811125A2 (pt) | imidazoquinolinas com propriedades imunomoduladoras | |
| IL193265A0 (en) | Quinoline derivatives | |
| ATE475662T1 (de) | Dihydropyrazolopyrimidinonderivate | |
| ATE483711T1 (de) | Spiroindolinonderivate | |
| DE602006016993D1 (de) | Gleitelement | |
| ATE469905T1 (de) | Pyridopyrimidinonderivate | |
| ATE512135T1 (de) | Spiroindolinonderivate | |
| NO20061669L (no) | SmartPlug with centralizer means | |
| DK2035394T3 (da) | 2-pyrazincarboxamidderivater | |
| EP2194044A4 (de) | Chinolonderivat | |
| ATE478050T1 (de) | Chinolinderivate mit 5-ht-bindenden eigenschaften | |
| DK1984225T3 (da) | Hjulophæng | |
| BRPI0715703A2 (pt) | anticorpos anti-c5ar com propriedades melhoradas | |
| ATE544764T1 (de) | 5-hydroxymethyloxazolidin-2-onderivate | |
| CR9458A (es) | Quinolonas y naftiridonas 7-amino alquilidenil heterociclicas | |
| DE502007007044D1 (de) | tsmaschinen mit Nebenstromkonfiguration | |
| ATE467619T1 (de) | Antibakterielle chinolinderivate | |
| BRPI0820432A2 (pt) | Derivados de fenilpirazol | |
| FI20070937L (fi) | Perhekeinu | |
| ATE527249T1 (de) | Indole | |
| ATE509915T1 (de) | Antibakterielle chinolinderivate | |
| DK2099760T3 (da) | Antibakterielle quinolinderivater | |
| DK2086941T3 (da) | Antibakterielle quinolinderivater | |
| DK1994020T3 (da) | Substituerede chinoloner III | |
| ATE486061T1 (de) | Antibakterielle chinolinderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 2076495 Country of ref document: EP |